Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04066036

Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

This is a prospective observational cohort study enrolling participants in South Africa and Uganda who are prescribed an HIV treatment regimen containing lamivudine, tenofovir, and dolutegravir, which is known as TLD. We hope to better understand how effective TLD will be in sub-Saharan Africa. If treatment failure occurs, we seek to understand the possible reasons, including drug resistance and adherence challenges.

Official title: Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa: A Prospective Observational Cohort Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

999

Start Date

2019-05-14

Completion Date

2023-05-31

Last Updated

2026-08-05

Healthy Volunteers

No

Conditions

Interventions

OTHER

This is an observational study only.

This is an observational study only.

Locations (2)

Africa Health Research Institute

Somkele, KwaZulu-Natal, South Africa

Mbarara University of Science and Technology

Mbarara, Uganda